ππ§ππ¨ππ«π’π§π¨π₯π¨π π²
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ππ§ππ¨ππ«π’π§π¨π₯π¨π π²
Apr 18, 2024, 13:47 |
Insight
Arndt Vogel: How to best manage Immune-Related Adverse Events?
Arndt Vogel, Managing Senior Consultant and Professor in the Department of Gastroenterology, Hepatology and Endocrinology…
Apr 16, 2024, 01:34 |
Insight
Arndt Vogel: Prognostic and predictive impact of sex in locally advanced Microsatellite instability (MSI) gastric or gastroesophageal junction cancer
Arndt Vogel, Managing Senior Consultant and Professor in the Department of Gastroenterology, Hepatology and Endocrinology…
Dec 30, 2023, 04:09 |
Drugs
Spencer Knight: Hereβs the current 34 approval breakdown by therapeutic area
Spencer Knight, Senior Business Consultant of Cell and Gene Therapy at Charlton Morris, shared on…
All:
3
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube
